Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Selective Time- and NADPH-Dependent Inhibition of Human CYP2E1 by Clomethiazole.

Stresser DM, Perloff ES, Mason AK, Blanchard AP, Dehal SS, Creegan TP, Singh R, Gangl ET.

Drug Metab Dispos. 2016 Aug;44(8):1424-30. doi: 10.1124/dmd.116.070193. Epub 2016 May 5.

PMID:
27149898
2.

Validation of cytochrome P450 time-dependent inhibition assays: a two-time point IC50 shift approach facilitates kinact assay design.

Perloff ES, Mason AK, Dehal SS, Blanchard AP, Morgan L, Ho T, Dandeneau A, Crocker RM, Chandler CM, Boily N, Crespi CL, Stresser DM.

Xenobiotica. 2009 Feb;39(2):99-112. doi: 10.1080/00498250802638155.

PMID:
19255936
3.

Differential time- and NADPH-dependent inhibition of CYP2C19 by enantiomers of fluoxetine.

Stresser DM, Mason AK, Perloff ES, Ho T, Crespi CL, Dandeneau AA, Morgan L, Dehal SS.

Drug Metab Dispos. 2009 Apr;37(4):695-8. doi: 10.1124/dmd.108.025726. Epub 2009 Jan 14.

PMID:
19144769
4.

David Kupfer, Ph.D. A mentor and a scientist.

Dehal SS.

Drug Metab Rev. 2006;38(1-2):13-22.

PMID:
16684645
5.

Human cytochrome p450 induction and inhibition potential of clevidipine and its primary metabolite h152/81.

Zhang JG, Dehal SS, Ho T, Johnson J, Chandler C, Blanchard AP, Clark RJ Jr, Crespi CL, Stresser DM, Wong J.

Drug Metab Dispos. 2006 May;34(5):734-7. Epub 2006 Feb 24.

PMID:
16501008
6.

In vitro inhibition of UDP glucuronosyltransferases by atazanavir and other HIV protease inhibitors and the relationship of this property to in vivo bilirubin glucuronidation.

Zhang D, Chando TJ, Everett DW, Patten CJ, Dehal SS, Humphreys WG.

Drug Metab Dispos. 2005 Nov;33(11):1729-39. Epub 2005 Aug 23.

PMID:
16118329
7.

Highly selective inhibition of human CYP3Aa in vitro by azamulin and evidence that inhibition is irreversible.

Stresser DM, Broudy MI, Ho T, Cargill CE, Blanchard AP, Sharma R, Dandeneau AA, Goodwin JJ, Turner SD, Erve JC, Patten CJ, Dehal SS, Crespi CL.

Drug Metab Dispos. 2004 Jan;32(1):105-12.

PMID:
14709627
8.
9.

Concurrent flavin-containing monooxygenase down regulation and cytochrome P450 induction by dietary indoles in the rat: implication for drug-drug interactions.

Williams DE, Katchamar S, Larsen-Su SA, Stresser DM, Dehal SS, Kupfer D.

Adv Exp Med Biol. 2001;500:635-8. No abstract available.

PMID:
11765009
11.

Interaction of methoxychlor and related compounds with estrogen receptor alpha and beta, and androgen receptor: structure-activity studies.

Gaido KW, Maness SC, McDonnell DP, Dehal SS, Kupfer D, Safe S.

Mol Pharmacol. 2000 Oct;58(4):852-8.

PMID:
10999957
12.

Concurrent flavin-containing monooxygenase down-regulation and cytochrome P-450 induction by dietary indoles in rat: implications for drug-drug interaction.

Katchamart S, Stresser DM, Dehal SS, Kupfer D, Williams DE.

Drug Metab Dispos. 2000 Aug;28(8):930-6.

PMID:
10901703
13.
16.

CYP2D6 catalyzes tamoxifen 4-hydroxylation in human liver.

Dehal SS, Kupfer D.

Cancer Res. 1997 Aug 15;57(16):3402-6.

18.

Tamoxifen metabolism by microsomal cytochrome P450 and flavin-containing monooxygenase.

Kupfer D, Dehal SS.

Methods Enzymol. 1996;272:152-63. No abstract available.

PMID:
8791773
19.
20.

Cytochrome P450 catalyzed covalent binding of methoxychlor to rat hepatic, microsomal iodothyronine 5'-monodeiodinase, type I: does exposure to methoxychlor disrupt thyroid hormone metabolism?

Zhou LX, Dehal SS, Kupfer D, Morrell S, McKenzie BA, Eccleston ED Jr, Holtzman JL.

Arch Biochem Biophys. 1995 Oct 1;322(2):390-4.

PMID:
7574712
24.
25.

Metabolism of Monoterpenes : Metabolic Fate of (+)-Camphor in Sage (Salvia officinalis).

Croteau R, El-Bialy H, Dehal SS.

Plant Physiol. 1987 Jul;84(3):643-8.

26.

Steroidal alpha-methylene delta-lactones as potential antitumor agents.

Dehal SS, Marples BA, Stretton RJ, Traynor JR.

J Med Chem. 1980 Jan;23(1):90-2.

PMID:
7359520

Supplemental Content

Loading ...
Support Center